BR0115473A - Inibidores de protease - Google Patents

Inibidores de protease

Info

Publication number
BR0115473A
BR0115473A BR0115473-7A BR0115473A BR0115473A BR 0115473 A BR0115473 A BR 0115473A BR 0115473 A BR0115473 A BR 0115473A BR 0115473 A BR0115473 A BR 0115473A
Authority
BR
Brazil
Prior art keywords
protease inhibitors
disease
amino
compounds
matrix
Prior art date
Application number
BR0115473-7A
Other languages
English (en)
Inventor
Dennis S Yamashita
Daniel F Veber
Robert W Marquis
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR0115473A publication Critical patent/BR0115473A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"INIBIDORES DE PROTEASE". A presente invenção provê inibidores de protease 4-amino-azepan-3-ona substituída por C~ 3~-C~ 6~ a-amino-1-acila cicloalcano e sais farmaceuticamente aceitáveis, hidratos e solvatos dos mesmos que inibem proteases, incluindo catepsina K, composições farmacêuticas desses compostos, intermediários novos desses compostos, e métodos para tratar doenças de perda óssea excessiva ou degradação de matriz ou cartilagem, incluindo osteoporose; doença gengival que inclui gengivite e periodontite; artrite, mais especificamente, osteoartrite e artrite reumatóide; doença de Paget; hipercalcemia de malignidade; e doença óssea metabólica, que compreende inibir a referida perda óssea ou degradação de matriz ou cartilagem excessiva pela administração a um paciente que necessita do mesmo, de um composto da presente invenção.
BR0115473-7A 2000-11-22 2001-11-19 Inibidores de protease BR0115473A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25250800P 2000-11-22 2000-11-22
PCT/US2001/051647 WO2003053331A2 (en) 2000-11-22 2001-11-19 Protease inhibitors

Publications (1)

Publication Number Publication Date
BR0115473A true BR0115473A (pt) 2004-09-28

Family

ID=22956303

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115473-7A BR0115473A (pt) 2000-11-22 2001-11-19 Inibidores de protease

Country Status (17)

Country Link
EP (1) EP1392657A4 (pt)
JP (1) JP2005513083A (pt)
KR (1) KR20040004445A (pt)
CN (1) CN1635903A (pt)
AR (1) AR034278A1 (pt)
AU (1) AU2001298052A1 (pt)
BR (1) BR0115473A (pt)
CA (1) CA2436850A1 (pt)
CZ (1) CZ20031403A3 (pt)
HU (1) HUP0301964A3 (pt)
IL (1) IL155997A0 (pt)
MX (1) MXPA03004542A (pt)
NO (1) NO20032328L (pt)
PL (1) PL366232A1 (pt)
UY (1) UY27032A1 (pt)
WO (1) WO2003053331A2 (pt)
ZA (1) ZA200303848B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
NZ520588A (en) 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
MXPA02012442A (es) * 2000-06-14 2003-04-25 Smithkline Beecham Corp Inhibidores de proteasa.
CN101970007A (zh) 2007-06-08 2011-02-09 日本化学医药株式会社 脑动脉瘤的治疗或预防药
US20100331545A1 (en) 2007-10-24 2010-12-30 Nippon Chemiphar Co., Ltd. Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511710A (en) * 1998-12-23 2003-12-19 Smithkline Beecham Corp 4-Amino-azepan-3-one derivatives useful as protease inhibitors
NZ520588A (en) * 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
MXPA02012442A (es) * 2000-06-14 2003-04-25 Smithkline Beecham Corp Inhibidores de proteasa.

Also Published As

Publication number Publication date
MXPA03004542A (es) 2003-09-10
IL155997A0 (en) 2003-12-23
NO20032328L (no) 2003-07-02
HUP0301964A3 (en) 2007-09-28
AR034278A1 (es) 2004-02-18
CN1635903A (zh) 2005-07-06
AU2001298052A1 (en) 2003-07-09
WO2003053331A2 (en) 2003-07-03
NO20032328D0 (no) 2003-05-22
PL366232A1 (en) 2005-01-24
CZ20031403A3 (cs) 2003-10-15
KR20040004445A (ko) 2004-01-13
EP1392657A4 (en) 2004-03-10
HUP0301964A2 (en) 2007-02-28
JP2005513083A (ja) 2005-05-12
EP1392657A2 (en) 2004-03-03
UY27032A1 (es) 2002-07-31
CA2436850A1 (en) 2003-07-03
WO2003053331A3 (en) 2003-11-13
ZA200303848B (en) 2004-06-28

Similar Documents

Publication Publication Date Title
BR9916488A (pt) Inibidores de protease
BR0109356A (pt) Inibidores de protease
AP9801222A0 (en) Proatease inhibitors.
NZ537853A (en) Inhibitors of cathepsin K and related cysteine protesases of the CA clan
BR0115427A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto
TR199902703T2 (xx) Proteaz inhibit�rleri.
BR0111693A (pt) Inibidores de protease
WO1999059526A3 (en) Protease inhibitors
BR0115473A (pt) Inibidores de protease
UY26088A1 (es) Inhibidores de proteasas
WO2002092563A3 (en) Protease inhibitors
UY26026A1 (es) Inhibidores de proteasas
ECSP992959A (es) Inhibidores de proteasa de bis- aminometil carbonilo
UY26771A1 (es) Inhibidores de proteasas
AR021971A1 (es) Inhibidores de proteasas
ECSP003403A (es) Inhibidores de proteasas xi
ECSP982486A (es) Inhibidores de proteasas ii
ECSP982481A (es) Inhibidores de proteasas
ECSP003353A (es) Inhibidores de proteasas ix
ECSP993293A (es) Inhibidores de proteasas viii
UY24550A1 (es) Inhibidores de proteasa
ECSP982493A (es) Inhibidores de proteasas iii

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]